Cost-Effectiveness Analysis of Ranibizumab

Ranibizumab cost-effectiveness analysis compared to intravitreal implantation of dexamethasone, triamcinolone, aflibercept and bevacizumab, for patients in the treatment of patients with macular edema secondary to central retinal vein occlusion in Colombia.

*Available in Spanish Only*